Drug recall · February 14, 2024
Febuxostat Tablets recall
Why: CGMP Deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Febuxostat Tablets, 40 mg, 30 Tablets (3 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-538-21, NDC Unit dose 60687-538-11
- Lots / codes
Lot # 1015033, exp. 06/30/2025; 1016409, exp. 08/31/2025
- Quantity
- 1,932 cartons
- Company
- Amerisource Health Services LLC, Columbus, OH
- Distribution
- USA Nationwide
- Initiated
- January 25, 2024 · Voluntary: Firm initiated
- Classified
- February 6, 2024
- Reported
- February 14, 2024
- Ended
- December 22, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Febuxostat
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.